Somatostatin and neuropeptide Y immunoreactivity in parkinson's disease dementia with alzheimer's changes-Reference-Cited by-同舟云学术

Somatostatin and neuropeptide Y immunoreactivity in parkinson's disease dementia with alzheimer's changes

Published:1988 Issue:4 Volume:2 Page:463-467
ISSN:0887-4476
Container-title:Synapse
language:en
Short-container-title:Synapse

Author:

Flint Beal M.,Clevens Ross A.,Mazurek Michael F.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Reference44 articles.

1. and (1987) Biochemistry of neurotransmitters in Parkinson's disease. In: Movement Disorders 2. and eds. Butterworths and Co., New York, pp. 166-230.

2. Dissociation of neuropeptide Y and somatostatin in Parkinson's disease

3. Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia

4. The Morphological Basis of Dementia in Parkinson’s Disease

5. Somatostatin-281–12-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross talk about the role of Neuropeptide Y in CNS disorders and diseases;Neuropeptides;2023-12

2. Somatostatin and cannabinoid receptors crosstalk in protection of huntingtin knock-in striatal neuronal cells in response to quinolinic acid;Neurochemistry International;2019-10

3. Neuropeptide Y Y 5 receptor localization in mouse central nervous system;Brain Research;2017-01

4. Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases;Neurobiology of Disease;2016-11

5. Quantitative mapping of the local and extrinsic sources of GABA and Reelin to the layer Ia neuropil in the adult rat neocortex;Brain Structure and Function;2013-07-02